The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Porcine Circovirus Type 2 (Pcv2) Subunit Vaccine - EP3035958

The patent EP3035958 was granted to Boehringer Ingelheim Animal Health USA on Oct 26, 2022. The application was originally filed on Aug 20, 2014 under application number EP14761742A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3035958

BOEHRINGER INGELHEIM ANIMAL HEALTH USA
Application Number
EP14761742A
Filing Date
Aug 20, 2014
Status
Granted And Under Opposition
Sep 23, 2022
Publication Date
Oct 26, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

CEVA SANTE ANIMALEJul 26, 2023CABINET BECKER ET ASSOCIESADMISSIBLE
VIRBACJul 25, 2023GEVERS & ORESADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2011305725
DESCRIPTIONUS2909462
DESCRIPTIONWO2006072065
DESCRIPTIONWO2008076915
INTERNATIONAL-SEARCH-REPORTCN103122352
INTERNATIONAL-SEARCH-REPORTWO2011116094
OPPOSITIONCN103122352
OPPOSITIONEP2657333
OPPOSITIONWO2006072065
OPPOSITIONWO2011116094
OPPOSITIONWO2012083837
OTHEREP2657333
OTHEREP3035958
OTHERWO2012083837

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents